Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07338968 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma

Study acronym: CoMpass
StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrolling by invitation only
    • Trial sites expanded: 0 → 10 locations
    • Start date changed from estimate of Feb 1, 2026 to Mar 27, 2026
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Aura Biosciences
6 trials monitored
See 1 trial at risk
Melanoma
1,092 trials monitored
See 60 trials at risk
AU-011-403 is a multicenter long-term follow-up safety and efficacy study of subjects with early CM who previously participated in the AU-011-301 Phase 3 trial. There are no required interventions or use of AU-011 (bel-sar) in this long-term follow-up study
Trial Details
NCT Number NCT07338968
Lead Sponsor Aura Biosciences
Conditions
(from sponsor)		 Choroidal Melanoma, Indeterminate Lesions
Related terms Uveal Melanoma
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov